A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older
Clinical trial NCT05603052 · COMPLETED
Trial details
- NCT number
- NCT05603052
- Sponsor
- EuBiologics Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2024-01-15
- Enrollment
- 2852
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.